GEP20022630B - Progesterone for Treating or Reducing Ischemia - Google Patents

Progesterone for Treating or Reducing Ischemia

Info

Publication number
GEP20022630B
GEP20022630B GEAP19974830A GEAP1997004830A GEP20022630B GE P20022630 B GEP20022630 B GE P20022630B GE AP19974830 A GEAP19974830 A GE AP19974830A GE AP1997004830 A GEAP1997004830 A GE AP1997004830A GE P20022630 B GEP20022630 B GE P20022630B
Authority
GE
Georgia
Prior art keywords
progesterone
treating
reducing ischemia
ischemia
reducing
Prior art date
Application number
GEAP19974830A
Inventor
William J Bologna
Howard L Levine
Original Assignee
Columbia Laboratories Bermuda Ltd Bm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24987712&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GEP20022630(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Columbia Laboratories Bermuda Ltd Bm filed Critical Columbia Laboratories Bermuda Ltd Bm
Publication of GEP20022630B publication Critical patent/GEP20022630B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1. Technical Result Increase in efficiency of treatment and reduce of complications. 2. Essence A progesterone is used for treating or reducing ischemia. 3. Field of Application Medicine.
GEAP19974830A 1996-11-04 1997-11-04 Progesterone for Treating or Reducing Ischemia GEP20022630B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/743,153 US5985861A (en) 1996-11-04 1996-11-04 Progesterone for treating or reducing ischemia

Publications (1)

Publication Number Publication Date
GEP20022630B true GEP20022630B (en) 2002-02-25

Family

ID=24987712

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP19974830A GEP20022630B (en) 1996-11-04 1997-11-04 Progesterone for Treating or Reducing Ischemia

Country Status (27)

Country Link
US (2) US5985861A (en)
EP (1) EP0956023B1 (en)
KR (1) KR100434623B1 (en)
CN (1) CN100341512C (en)
AR (1) AR009407A1 (en)
AT (1) ATE321558T1 (en)
AU (1) AU715740C (en)
BR (1) BR9710918A (en)
CA (1) CA2270565C (en)
DE (1) DE69735598T2 (en)
DK (1) DK0956023T3 (en)
ES (1) ES2262196T3 (en)
GE (1) GEP20022630B (en)
HK (1) HK1020534A1 (en)
HU (1) HUP9904045A3 (en)
IL (1) IL127455A (en)
LV (1) LV12342B (en)
MA (1) MA24391A1 (en)
MY (1) MY121627A (en)
NO (1) NO324278B1 (en)
NZ (1) NZ335306A (en)
PE (1) PE9899A1 (en)
PT (1) PT956023E (en)
RO (1) RO120607B1 (en)
UA (1) UA66772C2 (en)
WO (1) WO1998019681A1 (en)
ZA (1) ZA979862B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056972A (en) * 1997-02-26 2000-05-02 Dimera, Llc Method for reducing coronary artery reactivity
US6602487B1 (en) 1997-02-26 2003-08-05 Dimera Incorporated Methods and tests for producing and for inhibiting coronary artery vasospasms
DE69819748T2 (en) 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. MEDICINES FOR TREATING DYSMENORRHEA AND PREVIOUS BLIES
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
GB0107383D0 (en) * 2001-03-23 2001-05-16 Univ Edinburgh Lipid profile modulation
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US7572780B2 (en) * 2003-01-21 2009-08-11 Dimera, Incorporated Method and kit for reducing the symptoms of peripheral vascular disease
WO2004096151A2 (en) * 2003-04-29 2004-11-11 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
DE102005027004B4 (en) * 2005-06-10 2020-03-19 Continental Automotive Gmbh Windshield washer
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CA2713943C (en) * 2008-02-04 2018-10-23 Teva Women's Health, Inc. Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HRP20211377T1 (en) 2011-11-23 2022-01-07 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CA2951284A1 (en) 2014-07-29 2016-02-04 Therapeuticsmd, Inc. Transdermal cream
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
JP2019513709A (en) 2016-04-01 2019-05-30 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． Steroid hormone pharmaceutical composition
US11787835B2 (en) 2018-09-07 2023-10-17 Trustees Of Dartmouth College C19 scaffolds and steroids and methods of use and manufacture thereof
US11512107B2 (en) 2018-09-07 2022-11-29 Trustees Of Dartmouth College Methods for assembly of tetracyclic compounds by stereoselective C9-C10 bond formation
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1124906A1 (en) * 1982-05-25 1984-11-23 Ивановский государственный медицинский институт им.А.С.Бубнова Method of correcting ischemia injuries of preserved donor's kidney
US4615697A (en) * 1983-11-14 1986-10-07 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof

Also Published As

Publication number Publication date
CA2270565C (en) 2007-02-20
US6054447A (en) 2000-04-25
KR100434623B1 (en) 2004-06-05
AU5180198A (en) 1998-05-29
PT956023E (en) 2006-08-31
HK1020534A1 (en) 2000-05-12
NO324278B1 (en) 2007-09-17
PE9899A1 (en) 1999-02-08
AR009407A1 (en) 2000-04-12
DK0956023T3 (en) 2006-08-07
UA66772C2 (en) 2004-06-15
DE69735598D1 (en) 2006-05-18
CN100341512C (en) 2007-10-10
NZ335306A (en) 2000-12-22
AU715740B2 (en) 2000-02-10
RO120607B1 (en) 2006-05-30
MA24391A1 (en) 1998-07-01
LV12342A (en) 1999-09-20
KR20000053056A (en) 2000-08-25
BR9710918A (en) 2000-01-11
ZA979862B (en) 1998-05-25
CA2270565A1 (en) 1998-05-14
LV12342B (en) 2000-01-20
MY121627A (en) 2006-02-28
EP0956023A1 (en) 1999-11-17
NO992140D0 (en) 1999-05-03
CN1235549A (en) 1999-11-17
US5985861A (en) 1999-11-16
WO1998019681A1 (en) 1998-05-14
NO992140L (en) 1999-05-04
IL127455A (en) 2005-03-20
HUP9904045A2 (en) 2000-04-28
DE69735598T2 (en) 2006-12-28
ATE321558T1 (en) 2006-04-15
HUP9904045A3 (en) 2000-11-28
ES2262196T3 (en) 2006-11-16
IL127455A0 (en) 1999-10-28
AU715740C (en) 2004-04-29
EP0956023B1 (en) 2006-03-29

Similar Documents

Publication Publication Date Title
GEP20022630B (en) Progesterone for Treating or Reducing Ischemia
PL323825A1 (en) Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin
AU6915396A (en) Multiple sclerosis treatment
GEP20002146B (en) Therapeutic Peptide Derivatives
ZA95463B (en) Use of interleukin-12 to prevent graft-versus-host disease
PL320484A1 (en) Method of treating diabetes using kgf
MX9702035A (en) 5'alpha'-REDUCTASE INHIBITORS.
PH31319A (en) Method for treatment of autoimmune hepatitis.
GR3022030T3 (en) Composition for treating mastitis and metritis
DE3468212D1 (en) Monohydroxy-benzoyl peroxide and compositions for treating acne
PL322271A1 (en) Novel defined mixtures of enzymes for use in growing cells and healing wounds
CA2144728A1 (en) Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium
GR3036827T3 (en) Method and composition for the treatment of hair loss.
EP0350738A3 (en) (s)-emopamil for use in the treatment of migraine
PL308245A1 (en) Application of 4'-iodo-4'-desoxydoxorubicine in treating amyloidosis
UA43337C2 (en) Hormonal means for treating the blackheads
AU6251594A (en) Treatment of cancerous growths with biologically active peptides and protease inhibitors
EP0759781A4 (en) Method for treating and preventing atherosclerosis
AU7373196A (en) Combination of temozolomide and alpha-ifn for the treatment of advanced cancer
AU642173B2 (en) Improvements in or relating to a treatment and or a method of treating
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
IL123382A0 (en) Preparation for the prophylaxis and/or treatment of wool and hair loss
GEU1998397Y (en) Method for Primary Prestationary Treatment of the Wound
GB9625193D0 (en) Treatment of highly vascular tumours
AU3626893A (en) A blood pressure reducing food supplement and a method of treating hypertension in humans